Filing Details
- Accession Number:
- 0001179110-11-012414
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-18 20:01:39
- Reporting Period:
- 2011-08-17
- Filing Date:
- 2011-08-18
- Accepted Time:
- 2011-08-18 20:01:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1158223 | Affymax Inc | AFFY | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1419579 | Anne-Marie Duliege | C/O Affymax, Inc. 4001 Miranda Ave. Palo Alto CA 94304 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-08-17 | 5,296 | $4.73 | 24,704 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- In connection with the grant on September 22, 2010 of 30,000 shares of performance-based restricted stock units, 15,000 shares vested upon acceptance by the FDA of the NDA for peginesatide of which 5,296 shares were sold on August 17, 2011 pursuant to an order to satisfy tax withholding obligations that arose as a consequence of the vesting and delivery of the RSUs.